AxoGen gains capital with LecTec merger
This article was originally published in Clinica
Executive Summary
In a move to strengthen its cash flow, privately-held peripheral nerve repair specialist AxoGen has agreed to be merge with US healthcare investment company LecTec for an undisclosed fee. AxoGen said the financial support which it will gain from its cash-rich acquirer would help it grow sales of its three marketed products: the Avance nerve graft, the AxoGuard nerve protector, and the AxoGuard nerve connector.